Home » Topics » Regulatory

Regulatory
RSS

FDA approves Pristiq as therapy for adults with major depressive disorder

March 3, 2008

FDA approves Luvox CR Extended-Release capsules for SAD and OCD therapy

Feb. 29, 2008

FDA approves Arcalyst for cryopyrin-associated periodic syndromes (CAPS)

Feb. 29, 2008

FDA approves Abbott's Humira for polyarticular juvenile idiopathic arthritis

Feb. 25, 2008

FDA approves Abbott's Simcor, a combination therapy for cholesterol management

Feb. 18, 2008

FDA approves Emend for Injection as part of treatment for CINV

Jan. 30, 2008

Europe authorizes expanded use of The Medicines Company's Angiox in ACS

Jan. 29, 2008

Asahi Kasei obtains approval for recombinant thrombomodulin alpha

Jan. 29, 2008

Antibacterial Gracevit receives manufacturing and marketing approval in Japan

Jan. 28, 2008

Cangene's recombinant human growth hormone approved by the FDA

Jan. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...